1. Public Health England. National breast screening pathology audit 2020 [updated December 8th, 2020; accessed 21st August, 2021]. Available at: https://www.gov.uk/government/publications/national-breast-screening-pathology-audit/national-breast-screening-pathology-audit
2. Royal College of Pathologists. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. Royal College of Pathologists; 2021.
3. A ten-year, single-center experience: Concordance between breast core needle biopsy/vacuum-assisted biopsy and postoperative histopathology in B3 and B5a cases;Elsharkawy;PLoS One,2020
4. Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy;Bianchi;Breast,2011
5. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3);Houssami;Br J Cancer,2007